Market News for Eli Lilly & Co (LLY)
Lilly (LLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term....
Zacks Investment Research - 4/2/2026 8:06:06 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Eli Lilly's newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo Nordisk's head start in the oral market....
Reuters - 4/2/2026 7:28:56 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Eli Lilly has captured investors' attention in recent times thanks to its blockbuster weight loss drugs. The company dominates this valuable market in the U.S....
The Motley Fool - 4/2/2026 4:15:00 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
The drug, made by Eli Lilly, could offer a more convenient option for patients who want to avoid injections....
nytimes.com - 4/1/2026 4:14:52 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk’s Wegovy pill....
NBC News - 4/1/2026 4:00:42 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts....
investor.lilly.com - 4/1/2026 3:33:41 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
The U.S. Food and Drug Administration has approved Eli Lilly's oral weight-loss drug, orforglipron, branded as Foundayo, making it the second pill to enter the fast-growing obesity treatment market....
Reuters - 4/1/2026 3:07:31 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Eli Lilly shares jumped nearly 6% on Wednesday after the U.S. Food and Drug Administration approved its weight-loss pill, Foundayo, marking a significant milestone in the drugmaker's efforts to expand its foothold in the lucrative obesity market....
Reuters - 4/1/2026 2:21:20 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Eli Lilly opposes the White House's push to codify 'Most Favored Nations' drug pricing, Lilly CEO Dave Ricks said in an interview with CNBC. Lilly is one of more than a dozen pharmaceutical companies that have signed MFN deals with the Trump administration....
CNBC - 4/1/2026 1:32:41 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Eli Lilly and Co (NYSE:LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesity or those who are overweight with weight-related medical conditions, sending its shares more than 5% higher on Wednesday afternoon....
Proactive Investors - 4/1/2026 1:24:59 PM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Eli Lilly's Foundayo will be available to patients through the drugmaker's online pharmacy....
Barrons - 4/1/2026 11:50:00 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
The FDA go-ahead tees up a battle with rival Novo Nordisk over the next front in the booming weight-loss drug market....
WSJ - 4/1/2026 11:38:00 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
CNBC's Jim Cramer delivers his daily Mad Dash....
CNBC Television - 4/1/2026 11:31:52 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
Lilly is set to acquire Centessa for up to $7.8B, adds sleep disorder drugs and advances its push to diversify beyond obesity and diabetes treatments....
Zacks Investment Research - 4/1/2026 11:11:06 AM
More News for LLY
Stock Analysis for LLY
Related Stocks:
